259 related articles for article (PubMed ID: 28174746)
1. The Farnesoid X Receptor: Good for BAD.
Keely SJ; Walters JR
Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):725-732. PubMed ID: 28174746
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome.
Pereira-Fantini PM; Lapthorne S; Gahan CGM; Joyce SA; Charles J; Fuller PJ; Bines JE
Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):65-74. PubMed ID: 28560290
[TBL] [Abstract][Full Text] [Related]
3. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
4. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
Walters JR; Johnston IM; Nolan JD; Vassie C; Pruzanski ME; Shapiro DA
Aliment Pharmacol Ther; 2015 Jan; 41(1):54-64. PubMed ID: 25329562
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
6. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids.
Zhang JH; Nolan JD; Kennie SL; Johnston IM; Dew T; Dixon PH; Williamson C; Walters JR
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G940-8. PubMed ID: 23518683
[TBL] [Abstract][Full Text] [Related]
7. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
8. The role of bile acids in functional GI disorders.
Appleby RN; Walters JR
Neurogastroenterol Motil; 2014 Aug; 26(8):1057-69. PubMed ID: 24898156
[TBL] [Abstract][Full Text] [Related]
9. A Current Understanding of Bile Acids in Chronic Liver Disease.
Farooqui N; Elhence A; Shalimar
J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
[TBL] [Abstract][Full Text] [Related]
10. Obeticholic acid may increase the risk of gallstone formation in susceptible patients.
Al-Dury S; Wahlström A; Panzitt K; Thorell A; Ståhlman M; Trauner M; Fickert P; Bäckhed F; Fändriks L; Wagner M; Marschall HU
J Hepatol; 2019 Nov; 71(5):986-991. PubMed ID: 31254596
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis.
Ovadia C; Perdones-Montero A; Spagou K; Smith A; Sarafian MH; Gomez-Romero M; Bellafante E; Clarke LCD; Sadiq F; Nikolova V; Mitchell A; Dixon PH; Santa-Pinter N; Wahlström A; Abu-Hayyeh S; Walters JRF; Marschall HU; Holmes E; Marchesi JR; Williamson C
Hepatology; 2019 Jul; 70(1):276-293. PubMed ID: 30983011
[TBL] [Abstract][Full Text] [Related]
12. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
Hu X; Bonde Y; Eggertsen G; Rudling M
J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
[TBL] [Abstract][Full Text] [Related]
13. [Bile Acid Diarrhea].
Kim HJ; Kim HJ
Korean J Gastroenterol; 2024 Apr; 83(4):133-142. PubMed ID: 38659249
[TBL] [Abstract][Full Text] [Related]
14. Bile acid disease: the emerging epidemic.
Oduyebo I; Camilleri M
Curr Opin Gastroenterol; 2017 May; 33(3):189-195. PubMed ID: 28169840
[TBL] [Abstract][Full Text] [Related]
15. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
Johnston IM; Nolan JD; Pattni SS; Appleby RN; Zhang JH; Kennie SL; Madhan GK; Jameie-Oskooei S; Pathmasrirengam S; Lin J; Hong A; Dixon PH; Williamson C; Walters JR
Am J Gastroenterol; 2016 Mar; 111(3):423-32. PubMed ID: 26856750
[TBL] [Abstract][Full Text] [Related]
18. Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.
Ferrebee CB; Li J; Haywood J; Pachura K; Robinson BS; Hinrichs BH; Jones RM; Rao A; Dawson PA
Cell Mol Gastroenterol Hepatol; 2018; 5(4):499-522. PubMed ID: 29930976
[TBL] [Abstract][Full Text] [Related]
19. Bile Acid diarrhea: prevalence, pathogenesis, and therapy.
Camilleri M
Gut Liver; 2015 May; 9(3):332-9. PubMed ID: 25918262
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2.
Smyth JS; Truong JK; Rao A; Lin R; Foulke-Abel J; Adorini L; Donowitz M; Dawson PA; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G446-G452. PubMed ID: 37697930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
